Head of Early Discovery

Core responsibilities:

• Define and execute the early discovery strategy aligned with company objectives
• Oversee target identification, validation, and mechanism-of-action studies with a strong focus on oncology and immunology
• Lead and inspire a multidisciplinary, international team of scientists and research associates
• Spearhead initiatives to integrate advanced cellular and biochemical technologies, functional genomics platforms and fit-for-purpose screening systems

This role accelerates drug discovery by leveraging cutting-edge technologies and innovative scientific approaches to drive impactful therapies for patients, shaping Recursion's early discovery pipeline and translating programs into later development stages.

Required qualifications:

• PhD in Biology or related discipline
• 10+ years of postdoctoral experience in oncology and immunology
• Proven track record in target identification, validation, and translation into later stages of drug discovery
• Demonstrated ability to embrace and implement modern technologies (e.g., AI) in drug discovery
• Exceptional communication and leadership skills

Compensation and benefits:

• Estimated annual base salary range: $228,800 - $275,000 (USD)
• Eligible for annual bonus and equity compensation
• Comprehensive benefits package
• Hybrid work arrangement with office presence required at least 50% of the time